课题基金 / 基金详情

Dietary Folate: Impact on Prostate Tumor Biology, Genetics and Epigenetics

Dietary Folate: Impact on Prostate Tumor Biology, Genetics and Epigenetics
膳食叶酸:对前列腺肿瘤生物学、遗传学和表观遗传学的影响
批准号:
7587599
负责人:
DOMINIC JAMES SMIRAGLIA
金额:
$22.96万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-02-06 至 2010-11-30

项目摘要

项目成果

DOMINIC JAMES SMIRAGLIA的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 过去十年的流行病学研究表明,膳食叶酸(维生素B 9)摄入量与肝癌和肠癌的风险呈负相关。叶酸在一碳代谢中起核心作用,并通过促进dNTP生物合成而显著影响DNA合成。叶酸还通过促进S-腺苷甲硫氨酸(SAM)的生物合成来影响DNA甲基化,SAM是DNA甲基转移酶使用的甲基供体分子。前列腺上皮细胞对这些代谢途径的需求异常高,因为SAM由于这些细胞中异常高水平的多胺催化剂而通过脱羧作用从系统中被拉出。已知这些途径中的缺陷会导致遗传损伤以及以整体低甲基化和CpG岛特异性高甲基化形式的表观遗传损伤。我们假设前列腺对饮食中叶酸的操纵非常敏感,因为它对叶酸代谢途径的需求异常高。此外,我们预测,改变饮食叶酸可以影响前列腺癌(CaP)的致瘤进展,通过影响遗传和表观遗传损伤的致瘤过程的关键。我们将通过改变小鼠前列腺转基因腺癌(TRAMP)模型中的膳食叶酸来测试这一假设,该模型发展出与男性CaP相似的前列腺疾病的进行性阶段。我们将测试叶酸的饮食操作(与对照饮食相比,消耗和补充)将如何影响前列腺上皮细胞的生长和表型。此外,我们将在遗传和表观遗传水平上研究这些过程的分子机制。我们的研究结果将使我们能够建立一个机制之间的关系,饮食叶酸操纵和遗传/表观遗传损伤,驱动前列腺上皮肿瘤发生。CaP是一种生长缓慢的恶性肿瘤,通常在疾病开始和临床症状出现之间表现出很长的滞后期。叶酸的饮食控制可能提供一种有效的工具,以延迟和控制CaP从惰性状态发展到高度侵袭性状态。这样的饮食工具可能会导致CaP死亡率的大幅下降,使患者能够与非侵袭性疾病一起生活。公共卫生相关性:前列腺癌是美国男性中最常见的癌症。这项提案将研究膳食叶酸缺乏和补充对小鼠模型前列腺癌生物学的影响。我们预测,补充剂将通过支持前列腺细胞中需要叶酸的超负荷代谢途径来降低基因组完整性受损的速率。如果是这样,这可能对男性前列腺癌有非常重要的意义,使我们能够减缓男性前列腺癌的进展,从而显着降低这种疾病的死亡率。
英文摘要
DESCRIPTION (provided by applicant): Epidemiologic studies over the past decade suggest an inverse association of dietary folate (vitamin B9) intake with the risk of cancers of the liver and intestine. Folate plays a central role in one carbon metabolism and significantly impacts DNA synthesis by contributing to dNTP biosynthesis. Folate also impacts DNA methylation by contributing to biosynthesis of S-adenosylmethionine (SAM), the methyl donor molecule used by DNA methyltransferases. Prostate epithelial cells place an unusually high demand on these metabolic pathways because SAM is pulled from the system by decarboxylation due to the extraordinarily high level of polyamine catabolism in these cells. Deficiencies in these pathways are known to cause genetic damage as well as epigenetic damage in the form of global hypomethylation and CpG island specific hypermethylation. We hypothesize that the prostate is exquisitely sensitive to manipulation of folate in the diet due to its unusually high demand on the metabolic pathways folate is central to. Furthermore, we predict that altering dietary folate can influence the tumorigenic progression in prostate cancer (CaP) by influencing the genetic and epigenetic damage critical to the tumorigenic process. We will test this hypothesis by altering the dietary folate in the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) model that develops progressive stages of prostatic disease similar to CaP in men. We will test how dietary manipulation of folate (both depletion and supplementation compared to control diet) will affect prostate epithelium growth and phenotype. Further, we will investigate the molecular mechanisms underlying these processes at the genetic and epigenetic level. The results of our study will allow us to establish a mechanistic relationship between dietary folate manipulation and the genetic/epigenetic damage that drives tumorigenesis in prostatic epithelium. CaP arises as a slow-growing malignancy typically exhibiting a long lag period between initiation of disease and presentation of clinical symptoms. Dietary manipulation of folate might provide an effective tool to delay and control CaP progression from an indolent state to a highly aggressive state. Such a dietary tool could result in a major decrease in CaP mortality allowing patients to live with a non-aggressive disease. PUBLIC HEALTH RELEVANCE: Cancer of the prostate is the most commonly diagnosed cancer in American men. This proposal will study the effect of dietary folate deficiency and supplementation on the biology of prostate cancer in a mouse model. We predict that supplementation will reduce the rate at which the integrity of the genome is compromised by buttressing the over-burdened metabolic pathways requiring folate in prostate cells. If so, this could have very important implications for prostate cancer in men allowing us to slow the progression in men showing the very first signs of prostate cancer and therefore significantly reducing mortality from this disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Leveraging the methionine salvage pathway as a novel therapy for prostate cancer.
  • 批准号:
    9914224
  • 项目类别:
  • 资助金额:
    $37.82万
  • 财政年份:
    2016
  • 负责人:
    DOMINIC JAMES SMIRAGLIA
  • 依托单位:
Leveraging the methionine salvage pathway as a novel therapy for prostate cancer.
  • 批准号:
    9598104
  • 项目类别:
  • 资助金额:
    $5.49万
  • 财政年份:
    2016
  • 负责人:
    DOMINIC JAMES SMIRAGLIA
  • 依托单位:
Leveraging the methionine salvage pathway as a novel therapy for prostate cancer.
  • 批准号:
    9104867
  • 项目类别:
  • 资助金额:
    $38.94万
  • 财政年份:
    2016
  • 负责人:
    DOMINIC JAMES SMIRAGLIA
  • 依托单位:
Leveraging the methionine salvage pathway as a novel therapy for prostate cancer.
  • 批准号:
    9267430
  • 项目类别:
  • 资助金额:
    $38.94万
  • 财政年份:
    2016
  • 负责人:
    DOMINIC JAMES SMIRAGLIA
  • 依托单位:
海外基金